Psychosocial effects of COVID-19 measures on (pre-)dementia patients during second lockdown
Manuscript Number:
21-5342R2
Author(s):
Els D. Bakker, Femke H. Bouwman, Freek Gillissen, Evelien Lemstra, Arenda Mank, Philip Scheltens, Lisa Waterink, Marissa Zwan, Mardou van Leeuwenstijn, Ingrid S. van Maurik, Marleen van de Beek, Karlijn A. van den Bosch, Jennifer R. van den Broeke, Susanne van den Buuse, Wiesje M. van der Flier
Disclosures
Els D. Bakker
Nothing to Disclose
Femke H. Bouwman
Consulting Fees:
Biogen, advisory board for future clinical application of adecanumab
Payment to institution
Lecture Fees:
Roche, informative lecture for Roche employees
Payment to institution